DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Impact of Clomiphene Citrate Administration During the Early Luteal Phase on Endocrine Profile in IVF Cycles

Information source: Fundació Privada Eugin
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Female Infertility

Intervention: Clomifene Citrate (Drug)

Phase: Phase 4

Status: Completed

Sponsored by: Fundació Privada Eugin

Official(s) and/or principal investigator(s):
Marta Colodron, MD, Principal Investigator, Affiliation: Clinica EUGIN

Summary

The purpose of this study is to evaluate the effect on LH levels of the 5-day CC administration during luteal phase in oocyte donors, to investigate whether the CC corrects the suppressed LH levels in the luteal phase and whether it prolongs the luteal phase in the agonist triggered antagonist cycles.

Clinical Details

Official title: Impact of Clomiphene Citrate Administration During the Early Luteal Phase on Endocrine Profile in Agonist Triggered GnRH Antagonist in Vitro Fertilization Cycles. Phase IV, Single-centre, Open-label, Controlled Clinical Trial.

Study design: Allocation: Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Parallel Assignment, Masking: Open Label

Primary outcome: LH Levels (IU)

Secondary outcome: Endometrial development (Noyes criteria)

Eligibility

Minimum age: 18 Years. Maximum age: 35 Years. Gender(s): Female.

Criteria:

Inclusion Criteria:

- Oocyte donors

- 18-35 years old

- BMI 18-29 Kg/m2

- Normal basal hormonal levels

- No contraceptive pill

Exclusion Criteria:

- Polycystic ovarian syndrome (PCOS)

- Previous participation in the study

Locations and Contacts

Clínica EUGIN, Barcelona 08029, Spain
Additional Information

Starting date: June 2012
Last updated: February 12, 2013

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017